What is it about?
There are few reliable markers for payers to use to identify patients with schizophrenia who are at risk for relapse. Identification of warning signs prior to relapse may help payers develop disease management programs to help patients stay well. This study identified several claims-based "patient instability events (PIEs)" that summed to a total score to help predict potential risk for relapse.
Featured Image
Why is it important?
Identification of warning signs prior to relapse may help payers develop disease management programs to help patients stay well.
Perspectives
Schizophrenia is particularly difficult to treat, and relapse is devastating for patients and families. I hope this publication will provide one solution to improve lives for patients with schizophrenia and help patients stay well.
Heidi Waters
Otsuka Pharmaceutical Development & Commercialization, Inc.
Read the Original
This page is a summary of: Claims-based proxies of patient instability among commercially insured adults with schizophrenia, ClinicoEconomics and Outcomes Research, May 2018, Dove Medical Press,
DOI: 10.2147/ceor.s149519.
You can read the full text:
Contributors
The following have contributed to this page
